Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth

Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been over three years since my last Delcath Systems (NASDAQ: DCTH ) article , where I highlighted the company’s efforts in moving closer to submitting their NDA for their drug/device kit of melphalanHe is the leader of the investing group Compound ...